| 28th Apr 2020 7:00 am |
RNS |
Business Update |
| 17th Apr 2020 7:00 am |
RNS |
Parsortix performance in head and neck cancer |
| 3rd Mar 2020 7:00 am |
RNS |
Assessing risk of brain metastasis in lung cancer |
| 27th Feb 2020 7:00 am |
RNS |
Parsortix outperforms other CTC systems in RCC |
| 25th Feb 2020 7:00 am |
RNS |
ANGLE announce Tri-Con presentation with BioView |
| 17th Feb 2020 7:00 am |
RNS |
Data demonstrates key advantages of Parsortix |
| 11th Feb 2020 7:00 am |
RNS |
Study demonstrates Parsortix potential in melanoma |
| 3rd Feb 2020 9:10 am |
RNS |
Issue of Equity |
| 30th Jan 2020 7:00 am |
RNS |
Interim Results |
| 30th Jan 2020 7:00 am |
RNS |
Change of accounting reference date |
| 22nd Jan 2020 7:00 am |
RNS |
Successful face-to-face meeting with FDA |
| 8th Jan 2020 12:33 pm |
RNS |
Notice of Results |
| 23rd Dec 2019 9:55 am |
RNS |
Issue of Equity |
| 7th Nov 2019 7:00 am |
RNS |
Cancer centre shows Parsortix use in melanoma |
| 30th Oct 2019 2:44 pm |
RNS |
Result of AGM |
| 30th Oct 2019 7:00 am |
RNS |
Q-submission to FDA containing headline data |
| 8th Oct 2019 7:00 am |
RNS |
Notice of AGM |
| 4th Oct 2019 5:54 pm |
RNS |
Holding(s) in Company |
| 4th Oct 2019 7:00 am |
RNS |
European patent granted for megakaryocyte analysis |
| 13th Sep 2019 7:00 am |
RNS |
Use of Parsortix in head and neck cancer |
| 10th Sep 2019 7:00 am |
RNS |
Research with Parsortix in prostate cancer |
| 4th Sep 2019 7:00 am |
RNS |
Parsortix for Neuroendocrine Analysis in SCLC |
| 29th Aug 2019 7:00 am |
RNS |
Initiation of Ovarian Cancer Study |
| 31st Jul 2019 7:00 am |
RNS |
Prelim Results for the year ended 30 April 2019 |
| 22nd Jul 2019 7:00 am |
RNS |
Use of Parsortix for single cell analysis of CTCs |
| 16th Jul 2019 9:19 am |
RNS |
Holding(s) in Company |
| 12th Jul 2019 10:22 am |
RNS |
Result of General Meeting anf Total Voting Rights |
| 28th Jun 2019 1:37 pm |
RNS |
Notice of Preliminary Results and Webcast |
| 28th Jun 2019 1:08 pm |
RNS |
Holding(s) in Company |
| 25th Jun 2019 5:19 pm |
RNS |
Result of Placing |
| 25th Jun 2019 8:02 am |
RNS |
Accelerated bookbuild to raise £18.0m |
| 21st Jun 2019 7:00 am |
RNS |
Parsortix used to investigate immunotherapy target |
| 5th Jun 2019 7:00 am |
RNS |
Completion of Ovarian Cancer Pre-Study |
| 31st May 2019 7:00 am |
RNS |
Positive Results from FDA Clinical Study |
| 26th Apr 2019 7:00 am |
RNS |
IMMUNE SUPPRESSOR CELLS PROMOTE METASTASIS |
| 18th Apr 2019 7:00 am |
RNS |
Parsortix used in new cancer assessment technique |
| 12th Apr 2019 7:00 am |
RNS |
LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM |
| 4th Apr 2019 7:00 am |
RNS |
AACR 2019 |
| 11th Mar 2019 7:00 am |
RNS |
Holding(s) in Company |
| 7th Mar 2019 7:00 am |
RNS |
ENROLMENT COMPLETE FOR FDA CLINICAL STUDY |
